Pharma, Pharmaceutics and Biotechnology Conference

Neuropharmacology is that branch of pharmacology which focuses on the effects that drugs have upon the nervous system.

This lecture will discuss the mechanisms of drug action in the CNS and the role of neurotransmitters, and some therapeutic applications of neuropharmacological agents in the management of neurological and psychiatric disorders.

Understanding Neuropharmacology: Neuropharmacology is the study of how drugs affect the brain and behavior. Class of CNS drugs include antidepressants, antipsychotics, anxiolytics, and stimulants.

That session will look at the intricate inter-relationships between drugs and neurotransmitter systems, including Dopamine, Serotonin, Norepinephrine and GABA.

Drug mechanisms of action: This includes understanding pharmacodynamics as well as the pharmacokinetic properties of neuropharmacology agents; these encompass knowledge that is considered central to an understanding of receptor binding, signal transduction, genetic influences on drug response, and the impact of environment on drug effects.

Specific studies related to how a particular mechanism of drug action relates to a therapeutic effect or an adverse reaction in patients will be discussed.

Therapeutic Applications: Neuropharmacology forms the core of treating a variety of neurological and psychiatric disorders.

This session is going to be presented on the contemporary scenario for neuropharmacological therapy in depression, anxiety disorders, schizophrenia, epilepsy, and neurodegenerative diseases, including Alzheimer's and Parkinson's disease.

This includes recent advances in drug development along with the importance of personalized medicine in improving treatment outcomes. Neuropharmacological Challenges. Although the field has made major advances and evolved into a well-established discipline, neuropharmacology still faces challenges including drug efficacy and safety as well as treatment-resistant conditions.

This session will discuss challenges researchers and clinicians face in designing novel neuropharmacological agents or strategies to overcome these challenges, such as combination therapies and innovative drug delivery systems.

Emerging Trends; Tomorrow's Neuropharmacology. The light is at the end of the tunnel as scientists are working on new drug targets, response to treatment biomarkers, and the integration of technology in drug development.

The session on the emerging trends would be an eye-opener regarding gene therapy, personalized medicine, and artificial intelligence being incorporated in the drug development process, thereby changing our practice.

At the end of the session, the participants would have gained ample understanding and insight into principles and applications of neuropharmacology in contemporary medicine.